Vyrologix Best Performing & Safest enhancement to
Post# of 153875
(Total Views: 433)
Posted On: 03/06/2021 1:53:28 PM
Re: Riztheinvestor #81321
Vyrologix Best Performing & Safest enhancement to SOC for Critical COVID-19 Patients...
I share your frustration #Ritzinvestor and appreciate #TechGuru thoughts on the CD-12 results released so far, as you help explain things in a way so many of us can understand.
Is there not an option for the FDA to do the humane thing for Critical patients and not have a double blind placebo "Phase 4" or extension of Phase 3, but allow all in the trial to receive the SOC + Vyrologix? Is there not sufficient data on mortality rates of Critical COVID-19 sufferers to know when a treatment is added that is helping to save more lives?
Are there not sufficient results on Vyrologix to know whether it saves additional lives? If more numbers are required to show just how effective it is and who is best served by receiving it, please don't sacrifice lives with a Placebo arm...please do the right thing FDA!
On a personal note, several weeks ago, one of my employees (35 years old, non smoker, athletic, no other medical issues - I shared this with several on IH privately) was battling COVID and ended up in the ICU for 2 weeks. I tried all that I could to put his Dr. in touch with Dr. Kelly & Nader...they were both very responsive and tried what they could (which was just amazing to me), but in the end my employee's Dr. would not give Vyrologix a try as it was not FDA approved (he said if it had an EUA, he would have administered it!) ...In the end he recovered and after 6 weeks is finally back to work, but was a long hard fight for him and he would have been a prime case for Vyrologix.
GLTA!
I share your frustration #Ritzinvestor and appreciate #TechGuru thoughts on the CD-12 results released so far, as you help explain things in a way so many of us can understand.
Is there not an option for the FDA to do the humane thing for Critical patients and not have a double blind placebo "Phase 4" or extension of Phase 3, but allow all in the trial to receive the SOC + Vyrologix? Is there not sufficient data on mortality rates of Critical COVID-19 sufferers to know when a treatment is added that is helping to save more lives?
Are there not sufficient results on Vyrologix to know whether it saves additional lives? If more numbers are required to show just how effective it is and who is best served by receiving it, please don't sacrifice lives with a Placebo arm...please do the right thing FDA!
On a personal note, several weeks ago, one of my employees (35 years old, non smoker, athletic, no other medical issues - I shared this with several on IH privately) was battling COVID and ended up in the ICU for 2 weeks. I tried all that I could to put his Dr. in touch with Dr. Kelly & Nader...they were both very responsive and tried what they could (which was just amazing to me), but in the end my employee's Dr. would not give Vyrologix a try as it was not FDA approved (he said if it had an EUA, he would have administered it!) ...In the end he recovered and after 6 weeks is finally back to work, but was a long hard fight for him and he would have been a prime case for Vyrologix.
GLTA!
(6)
(0)